A serum developed by Yale researchers reduces infection from malaria, according to a new study. It works by attacking a protein in the saliva of the mosquitos infected with the malaria parasite rather than the parasite itself. Read more about it here.
Study Explores New Strategy to Develop a Malaria Vaccine
